Halberd Corporation (HALB)
Develops drug treatments for brain diseases like Alzheimer's and PTSD
$0.00+0.00%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-58.3%
The outlook
HALB is trading near the bottom of its 52-week range at $0.001, with a bearish lean from analysts and mixed signals from its recent price trend. The stock sits well below its highs over the past year, reflecting sustained weakness. Coverage appears minimal given the price point and overall sentiment score.
What’s behind the score
Price trendMixed vs its moving averages
52-week range18% of the way from its 52-week low to high
Market cap
$707,303
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—